Pharmacokinetics of hydroxocobalamin in smoke inhalation victims

Clinical Toxicology

Volumn 34, Issue 4, 1996, Pages 397-404

  Houeto, Paul ^a   Borron, Stephen W ^a   Sandouk, Pierre ^a,b   Imbert, Michel ^c   Levillain, Pierre ^a   Baud, Frederic J ^a  

^a HÔPITAL FERNAND WIDAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Brigade Sapeurs pompiers   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CYANIDE; HYDROXOCOBALAMIN;

ADULT; AGED; COMPARTMENT MODEL; CONFERENCE PAPER; CONTROLLED STUDY; CYANIDE POISONING; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; HUMAN; HUMAN EXPERIMENT; INHALATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; SMOKE;

ADULT; AGED; AGED, 80 AND OVER; ANTIDOTES; CREATININE; CYANIDES; FEMALE; HALF-LIFE; HUMANS; HYDROXOCOBALAMIN; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SMOKE INHALATION INJURY; TIME FACTORS;

EID: 0029680741     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563659609013809     Document Type: Conference Paper

References (26)

1. Baud FJ, Barriot P, Toffis V, et al. Elevated blood cyanide concentrations in victims of smoke inhalation. N Engl J Med 1991;325:1761-1766.
2. Ballantyne B. Hydrogen cyanide as a product of combustion and a factor in morbidity and mortality from fires. In: Clinical and Experimental Toxicology of Cyanides, Ballantyne B, Marrs T, eds. , Bristol, England: John Wright, 1987:248-291.
3. Terrill JB, Montgomery RR, Reinhardt CF. Toxic gases from fires. Science 1978;200:1343-1347. (Pubitemid 8373552)
4. Graham DL, Laman D, Theodore J, Robin ED. Acute cyanide poisoning complicated by lactic acidosis and pulmonary edema. Arch Intern Med 1977;137: 1051-1055. (Pubitemid 9033756)
5. Bismuth C, Cantineau J, Pontal P, et al. Priority de l'oxygenation dans l'intoxication cyanhydrique. J Toxicol Med 1984;4:107-121. (Pubitemid 14065964)
6. Mushett CW, Kelley KL, Boxer GE, Rickards JC. Antidotal efficacy of vitamin B12a (hydroxo-cobalamin) in experimental cyanide poisoning. Proc Soc Exp Biol Med 1952;81:234-237.
7. Riou B, Baud F, Astier A, Barriot P, Lecarpentier Y. In vitro demonstration of antidotal efficacy of hydroxocobalamin in cyanide poisoning. J Neurosurg Anesthesiol 1990;2:296-304.
8. Riou B, Baud FJ, Renaud C, Bismuth C. L'hydroxocobalamin. In: Les antidotes, Baud F, Barriot P, Riou B, eds. Paris: Masson, 1992:175-193.
9. Riou B, Berdeaux A, Pussard E, Giudicelli JF. Comparison of the hemodynamic effects of hydroxocobalamin and cobalt edetate at equipotent cyanide antidotal doses in conscious dogs. Intens Care Med 1993;19:26-32. (Pubitemid 23081481)
10. Moore SJ, Norris JC, Walsh DA, Hume AS. Antidotal use of methemoglobin forming cyanide antagonists in concurrent carbon monoxide/cyanide intoxication. J Pharmacol Exp Ther 1987;242:70-73. (Pubitemid 17112261)
11. de La Coussaye JE, Houeto P, Sandouk P, Levillain P, Sasine A, Riou B. Pharmacokinetics of hydroxocobalamin in dogs. J Neurosurg Anesthesiol 1994;6: 111-115. (Pubitemid 24094181)
12. Yacoub M, Faure J, Morena H, Vincent M, Faure H. [Acute hydrocyanic acid intoxication. Current data on the metabolism of cyanide and treatment by hydroxocobalamin]. Eur J Toxicol Environ Hyg 1974; 7:22-29.
13. Cottrell JE, Casthely P, Brodie JD, Patel K, Klein A, Turndorf H. Prevention of nitroprusside-induced cyanide toxicity with hydroxocobalamin. N Engl J Med 1978;298:809-811. (Pubitemid 8313453)
14. Favier C, Baud FJ, Richter F, Imbert M. Tolerance of high doses of hydroxocobalamin (OHCO) in fire victims. Clin Intens Care 1993;4:69.
15. Auzepy P, Veissiere J, Deparis M. [Letter: Anaphylactic shock due to hydroxocobalamin]. Nouv Presse Med 1974 ;3:152.
16. Hillman RS. Vitamin B12, folic acid, and the treatment of megaloblastic anemias. In: The Pharmacological Basis of Therapeutics. Gilman A, Goodman L, Rail T, Murad F, eds. , New York: Mac Millan, 1985:1323-1337.
17. Shearman DJ, Calvert JA, Ala FA, Girdwood RH. Renal excretion of hydroxocobalamin in man. Lancet 1965;2:1328-1330.
18. Forsyth JC, Mueller PD, Becker CE, et al. Hydroxocobalamin as a cyanide antidote: safety, efficacy, and pharmacokinetics in heavily smoking normal volunteers. / Toxicol Clin Toxicol 1993;31: 277-294. (Pubitemid 23159971)
19. Houeto P, Buneaux F, Galliot-Guilley M, Baud FJ, Levillain P. Determination of hydroxocobalamin and cyanocobalamin by derivative spectrophotometry in cyanide poisoning. J Anal Toxicol 1994;18:154-158. (Pubitemid 24148280)
20. Rieders F. Cyanide. In: Methodology for Analytical Toxicology. Sunshine I, ed. , Cleveland: CRC Press, 1975:113-118, vol 1.
21. Ballantyne B, Marrs TC. Post-mortem features and criteria for the diagnosis of acute lethal cyanide poisoning. In: Clinical and Experimental Toxicology of Cyanides. Ballantyne B, Marrs TC, eds. , Bristol: John Wright, 1987:217-247.
22. Moureu H, Chovin P, Truffert L, Lebbe J. Nouvelle micromethode pour la determination rapide et precise de Foxycarbonemie par absorption selective dans 1'infrarouge. Arch Mai Prof 1957;18:116-124.
23. Schwartz D. Methodes statistiques a I'usage des medecins et des biologistes. Paris: Flammarion, 1963.
24. Evans CL. Cobalt compounds as antidotes for hydrocyanic acid. Br J Pharmacol 1964;23:455-475.
25. Astier A, Baud FJ. Simultaneous determination of hydroxocobalamin and its cyanide complex cyanocobalamin in human plasma by high performance liquid chromatography. Application to pharmacokinetic studies after high-dose hydroxocobalamin as an antidote for severe cyanide poisoning. J Chromatogr B Biomed Appl 1995;667:129-135.
26. Dedrick RL, Bischoff KB, Zaharko DS. Interspecies correlation of plasma concentration history of methotrexate (NSC-740). Cancer Chemother Rep 1970;54:95-101.